Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Puma Biotechnology announced the grant of an inducement award to a November new hire, as required under Nasdaq Listing Rule ...
Pancreatic cancer patient survival doubled with high dose of common vitamin, study finds
The researchers found that administering 75 grams of vitamin C three times a week doubled overall survival rates of patients ...
jhuapl5h
From the Battlefield to Breast Cancer Detection, Johns Hopkins APL Technologies Find Dual Impact
APL researchers used artificial intelligence and two APL-patented imaging technologies to improve the accuracy and efficiency ...
Owners of boutique in Ross, South Hills donate sweaters to honor loved one’s memory
When Julie Durbin was undergoing cancer treatment, she was always cold. She would bring a cardigan, a sweater that opens in ...
Hosted on MSN6h
Merck's ADC Drug Gets FDA Breakthrough Therapy Tag in NSCLC
Merck MRK announced that the FDA has granted breakthrough therapy designation (BTD) to sacituzumab tirumotecan (sac-TMT) for ...
Science Daily7h
Long-term benefit from anti-hormonal treatment is influenced by menopausal status
Today, women with estrogen-sensitive breast cancer receive anti-hormonal therapy. Researchers now show that postmenopausal ...
How breast cancer cells survive in bone marrow after remission
A study from researchers at the University of Michigan and the University of California San Diego has shed light on a ...
Baylor College of Medicine13h
Baylor and Rice receive $2.3 million to develop antibody therapy for metastatic breast cancer
Researchers at Baylor College of Medicine and Rice University have received a $2.3 million Breakthrough Award from the ...
How NJ cancer survivors are guiding new patients through 'the storm' after diagnosis
Linda D’Addario, a cancer survivor, now mentors others through Cancer Hope Network, a program now available at five area ...
Paudling Progress1d
Andrea S. Schad 1974-2024
Schad, a compassionate soul and dedicated community member, passed away on Friday, November 29, 2024, at the age of 50 at CHP ...
GlobalData on MSN1d
Novartis and Olema expand alliance with $250m to boost breast cancer trials
Olema Oncology plans to start a Phase III trial studying palazestrant with a CDK4/6 inhibitor from Novartis in mid-2025.
Business Wire1d
Lantern Pharma's Investigational Drug-Candidate, LP-184, Receives Second Fast Track Designation from FDA for Treatment of Triple Negative Breast Cancer (TNBC)
Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, ...